K
Kazia Therapeutics Limited D
D
KZIA
10.970
USD
-0.80
(-6.80%)
مغلق
حجم التداول
8,181
الربح لكل سهم
-2
العائد الربحي
-
P/E
-1
حجم السوق
170,571,192
المقالات
العنوان: Kazia Therapeutics Limited
القطاع: الرعاية الصحية
الصناعة: Biotechnology
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.